MedMarket Diligence, LLC

The clinical need and patient-driven demand for aesthetic and reconstructive surgery is driving global sales of implants, materials and other products. MedMarket Diligence's worldwide report analyzes the market and its opportunities.

Growth in post-recession disposable income and an expanding number of options in the demand for aesthetics are driving procedures at double digit levels.

Growth factors, tissue engineering and skin substitutes are combining with traditional wound care products that will drive the global market from over $12 billion in 2013 to near $19 billion in 2021, according to a new MedMarket Diligence report.

Wound care products have evolved in a continuum from simple wound coverings, closures, dressings, and bandages through sophisticated dressing materials that regulate moisture, control exudate, actively prevent infection and advanced technologies for skin.

Considering a wide range of dressing types and the more novel negative pressure wound therapy and bioengineered skin/substitutes, global wound product sales will reach nearly $13 billion in 2013, according to a new MedMarket Diligence report.

MedMarket Diligence has released a comprehensive dataset of the global market for spine surgery technologies. Previously released as a worldwide report, the data is now being released in spreadsheet for rapid use by spine surgery stakeholders.

Fibrin-based and other biologically based and synthetic sealants and glues are steadily penetrating traditional wound closure dominated by sutures and staples. This 2012 report from MedMarket Diligence reveals the global outlook for these products.

Manufacturers of products for hemostasis, closure, and sealing of wounds are developing and introducing many new products globally that exploit increasing physician adoption of these wound technologies, according to a 2012 MedMarket Diligence report.

Competing against sutures and staples, advanced wound closure, sealing, hemostasis and anti-adhesion products are steadily gaining revenues. A new February 2012 report from MedMarket Diligence details this global $14 billion market.

Products for hemostasis, sealing, closure and other wound management reflect diverse technologies, as advanced types steadily make inroads in to traditional wound products. MedMarket Diligence has published its 2012 global analysis of this market.